Tag: health technology
Top News
Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer...
Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.
- Our Sponsors Ad -